Hatice Ulku Osmanbeyoglu (Hatice U Osmanbeyoglu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Nature communications

Cancer research communications

bioRxiv : the preprint server for biology

Communications biology

University of Pittsburgh

University of Pittsburgh (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Nov 03 2018

United States

Assistant Professor :: Biomedical Informatics

Memorial Sloan Kettering Cancer Center Mar 01 2013 - Nov 30 2018

United States

Postdoctoral Associate :: Computational & Systems Biology Program

Education History

University of Pittsburgh Aug 30 2009 - Dec 15 2012

United States

PHD :: Biomedical Informatics

Publications

Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Xiaojun Ma, David Lembersky, Elena S Kim, Michael J Becich, Joseph R Testa, Tullia C Bruno, Hatice Ulku Osmanbeyoglu
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments. Cancer research communications 4 (8) (2024)
Xiaojun Ma, David Lembersky, Elena S Kim, Michael J Becich, Joseph R Testa, Tullia C Bruno, Hatice Ulku Osmanbeyoglu
Spatial landscape of malignant pleural and peritoneal mesothelioma tumor immune microenvironment. Cancer research communications (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice Ulku Osmanbeyoglu, Andres J Klein-Szanto, Kathy Q Cai, Joseph R Testa
Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment. Cancer research communications 4 (4) (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Linan Zhang, April Sagan, Bin Qin, Baoli Hu, Hatice Ulku Osmanbeyoglu
STAN, a computational framework for inferring spatially informed transcription factor activity across cellular contexts. bioRxiv : the preprint server for biology (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice Ulku Osmanbeyoglu, Andres J Klein-Szanto, Kathy Q Cai, Joseph R Testa
Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment. Cancer research communications 4 (4) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Xiaojun Ma, David Lembersky, Elena S Kim, Michael J Becich, Joseph R Testa, Tullia C Bruno, Hatice Ulku Osmanbeyoglu
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments. Cancer research communications 4 (8) (2024)
Xiaojun Ma, David Lembersky, Elena S Kim, Michael J Becich, Joseph R Testa, Tullia C Bruno, Hatice Ulku Osmanbeyoglu
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments. Cancer research communications 4 (8) (2024)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Communications biology 7 (1) (2024)
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Daniel Brown, Priscilla McAuliffe, Adrian V Lee, Steffi Oesterreich, Ioannis K Zervantonakis, Hatice Ulku Osmanbeyoglu
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. bioRxiv : the preprint server for biology (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Koushul Ramjattun, Xiaojun Ma, Shou-Jiang Gao, Harinder Singh, Hatice Ulku Osmanbeyoglu
COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells. Journal of medical virology 95 (6) (2023)
Linan Zhang, Sandra Cascio, John W Mellors, Ronald J Buckanovich, Hatice Ulku Osmanbeyoglu
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. bioRxiv : the preprint server for biology (2023)
Yifeng Tao, Xiaojun Ma, Drake Palmer, Russell Schwartz, Xinghua Lu, Hatice Ulku Osmanbeyoglu
Interpretable deep learning for chromatin-informed inference of transcriptional programs driven by somatic alterations across cancers. Nucleic acids research 50 (19) (2022)
Hatice Ulku Osmanbeyoglu, Drake Palmer, April Sagan, Eleonora Sementino, Michael J Becich, Joseph R Testa
Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response. Cancers 14 (22) (2022)
Xiaojun Ma, Ashwin Somasundaram, Zengbiao Qi, Douglas J Hartman, Harinder Singh, Hatice Ulku Osmanbeyoglu
SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators. Nucleic acids research 49 (17) (2021)
Avani Vyas, R Alex Harbison, Daniel L Faden, Mark Kubik, Drake Palmer, Qing Zhang, Hatice Ulku Osmanbeyoglu, Kirill Kiselyov, Eduardo Méndez, Umamaheswar Duvvuri
Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Hatice Ulku Osmanbeyoglu, Fumiko Shimizu, Angela Rynne-Vidal, Direna Alonso-Curbelo, Hsuan-An Chen, Hannah Y Wen, Tsz-Lun Yeung, Petar Jelinic, Pedram Razavi, Scott W Lowe, Samuel C Mok, Gabriela Chiosis, Douglas A Levine, Christina S Leslie
Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers. Nature communications 10 (1) (2019)

Hatice Ulku Osmanbeyoglu.css-eqlu8i{font-size:small;padding-left:4px;} (Hatice U Osmanbeyoglu)

Publication Activity (10 Years)

Top Topics

Top Venues

Hatice Ulku Osmanbeyoglu (Hatice U Osmanbeyoglu)